https://stock.noler.com/us/stock/rich-pharmaceuticals-inc https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/acquired-finite-lived-intangible-asset-amount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/assets-noncurrent https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/bank-overdrafts https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cash-change https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/commitments-and-contingencies https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/convertible-notes-payable https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cost-of-services https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-conversion-converted-instrument-rate https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-securities-realized-gain-loss https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-rent-receivables-net https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/due-from-officers-or-stockholders-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/fair-value-investments-entities-that-calculate-net-asset-value-per-share-unobservable-input-gains-losses-included-in-earnings-assets-and-liabilities-continued-to-be-held-amount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-gain-loss-included-in-oci-loss https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-due-from-officers-and-stockholders https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-due-to-officers-and-stockholders https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-marketable-securities-restricted https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-notes-receivable-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/intangible-assets-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/intangible-assets-net-including-goodwill https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/labor-and-related-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/liabilities-noncurrent https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/loans-and-leases-receivable-related-parties-additions https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/loans-payable-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/new-shares-sold https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/notes-and-loans-receivable-gross-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/paid-in-capital-dividends-in-excess-of-retained-earnings https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/payments-for-proceeds-from-investments https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/payments-for-proceeds-from-loans-and-leases https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/proceeds-from-repayments-of-bank-overdrafts https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/professional-and-contract-services-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/property-plant-and-equipment-gross-excluding-capital-leased-assets https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/property-plant-and-equipment-other-accumulated-depreciation https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shares-held-in-employee-stock-option-plan-committed-to-be-released https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shares-issued-2 https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/travel-and-entertainment-expense https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/valuation-allowance-amount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/rich-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted